Translating Prognostic and Predictive Biomarkers into ClinicFriday, 20 April 2012 at 14:15 Add to Calendar ▼2012-04-20 14:15:002012-04-20 15:15:00Europe/LondonTranslating Prognostic and Predictive Biomarkers into ClinicSELECTBIOenquiries@selectbiosciences.com The ongoing efforts for biomarker discovery, validation and translation, and several successes that have guided clinical practice including MammaPrint testing for breast cancer prognosis and ALK fusion screening as companion diagnostics for Crizotinib treatment will be discussed. |